Arla Foods Ingredients unveils new micellar casein for medical nutrition

DENMARK – Arla Foods Ingredients, a global leader in dairy-based nutrition solutions, has launched a new micellar casein isolate (MCI) ingredient under its Lacprodan MicelPure portfolio, aimed at addressing the rising demand for high-quality medical nutrition products. 

The announcement, made ahead of Vitafoods Europe 2025, highlights the company’s focus on improving protein malnutrition solutions with enhanced taste and texture.

The new Lacprodan MicelPure ingredient is designed to meet the needs of patients requiring medical nutrition, particularly those facing protein deficiencies. 

According to Arla Foods Ingredients, the micellar casein isolate offers a milky, neutral taste, making it versatile for pairing with various flavors to improve patient compliance. 

This is critical, as taste and texture significantly influence adherence to medical nutrition plans. 

Mads Dyrvig, head of Sales Development for Specialised Nutrition at Arla Foods Ingredients, stated, “Our Lacprodan MicelPure solutions are a great match for medical nutrition products targeting protein malnutrition, helping enhance recovery and quality of life.”

The global micellar casein market is experiencing robust growth, with projections estimating an increase from US$1.7 billion in 2025 to US$4.5 billion by 2032, driven by rising health awareness and demand for high-protein foods. 

Arla Foods Ingredients is positioning itself to capitalize on this trend by expanding its portfolio to include ingredients that support clinical nutrition. 

The company’s latest offering is expected to cater to the growing need for products that combine high protein content with appealing sensory qualities, addressing common barriers to patient adherence such as unpalatable textures or flavors.

This launch follows Arla Foods Ingredients’ recent efforts to strengthen its medical nutrition offerings, including the acquisition of Volac’s Whey Nutrition division in November 2024 for an undisclosed amount. 

The move has bolstered its production capabilities, with the Felinfach site in Wales now serving as a global hub for performance and health nutrition. 

As the company continues to innovate, its focus remains on delivering solutions that improve patient outcomes through better nutrition.

Subscribe to our email newsletters that provide busy executives like you with the latest news insights and trends from Africa and the World. SUBSCRIBE HERE